Globe Newswire UB-312 is the first Parkinson's candidate to reduce pathology as measured by a seed amplification assay, and suggest clinical improvement on motor experiences of daily living. Data demonstrates...\n more…
InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nVaxxinity stock is rising higher on Friday with heavy trading of VAXX shares as it remains volatile ahead of its delisting next...\n more…
Benzinga Shares of Vaxxinity, Inc. VAXX fell sharply during Monday's session after the company announced its intention to voluntarily delist and deregister its Class A common stock. Vaxxinity shares dipped 54.8% to $0.2150 on Monday. Here are some other stocks moving in today's mid-day session. Matterport, Inc. MTTR shares jumped 184% to $4.93.\n more…
InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nVaxxinity stock is falling hard on Monday after the company announced plans to voluntarily delist shares of VAXX stock next month.\nThe...\n more…